ME

MEDIPOSTCO.,LTD.

Develops cord blood stem cell therapies for osteoarthritis & infant lung disease, plus banking.

078160 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 대왕판교로 644번길21 -, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

MEDIPOST CO., LTD. is a global biotechnology company specializing in the development and commercialization of umbilical cord blood-derived stem cell therapeutics. The company focuses on regenerative medicine to address unmet medical needs. Its commercialized portfolio includes first-generation products such as CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. Alongside its therapeutic endeavors, MEDIPOST operates a significant private cord blood banking division for the collection and storage of stem cells. The company's research and development pipeline includes next-generation injectable and intravenous treatments for conditions like osteoarthritis (SMUP-IA-01) and diabetic nephropathy (SMUP-IV-01).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-03 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2025-09-01 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.4 KB
2025-08-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-07-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.5 KB
2025-06-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.3 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.9 MB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-28 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 14.6 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 36.3 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.1 KB
2025-03-20 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 735.7 KB
2025-03-17 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 1.4 MB
2025-03-13 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 1.4 MB

Automate Your Workflow. Get a real-time feed of all MEDIPOSTCO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for MEDIPOSTCO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.